Incorporating Management of Clonal Hematopoiesis of Indeterminate Potential Into Cardiovascular Practice

Circulation. 2025 Oct 7;152(14):975-977. doi: 10.1161/CIRCULATIONAHA.125.075769. Epub 2025 Oct 6.

Authors

Ohad Oren¹, Peter Libby²

Affiliations

¹ Cardiology Division, Massachusetts General Hospital, Boston (O.O.).
² Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (P.L.).

No abstract available

Keywords: atherosclerosis; cardiovascular diseases; clonal hematopoiesis; inflammation, risk stratification, precision medicine; risk factor.

Grants and funding